Overview

Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the bioavailability of TAS-102 tablets to an oral solution containing equivalent amounts FTD and TPI.
Phase:
Phase 1
Details
Lead Sponsor:
Taiho Oncology, Inc.
Treatments:
Pharmaceutical Solutions
Trifluridine